Literature DB >> 19788484

Vertebroplasty in the management of traumatic burst fractures: a case series.

O Doody1, C Czarnecki, M F Given, Stuart M Lyon.   

Abstract

This study aimed to assess the role of percutaneous vertebroplasty (VP) in the management of acute traumatic burst fractures. We describe three cases where percutaneous VP was carried out for traumatic non-osteoporotic burst vertebral fractures. For clinical symptoms and the effect of the VP procedure to be assessed, all patients completed a visual analogue scale and a mobility score before the procedure and at day 1 and 3 months post procedure. Improvements in both pain and mobility scores immediately post procedure were seen in all patients, and these results persisted at 3-month follow up. Percutaneous VP provided a successful, minimally invasive treatment of these patients' traumatic fractures while avoiding major surgical procedures and associated surgical morbidity and complications.

Entities:  

Mesh:

Year:  2009        PMID: 19788484     DOI: 10.1111/j.1754-9485.2009.02095.x

Source DB:  PubMed          Journal:  J Med Imaging Radiat Oncol        ISSN: 1754-9477            Impact factor:   1.735


  3 in total

1.  Experimental and computational approach investigating burst fracture augmentation using PMMA and calcium phosphate cements.

Authors:  Sami M Tarsuslugil; Rochelle M O'Hara; Nicholas J Dunne; Fraser J Buchanan; John F Orr; David C Barton; Ruth K Wilcox
Journal:  Ann Biomed Eng       Date:  2014-01-07       Impact factor: 3.934

2.  Development of calcium phosphate cement for the augmentation of traumatically fractured porcine specimens using vertebroplasty.

Authors:  Sami M Tarsuslugil; Rochelle M O'Hara; Nicholas J Dunne; Fraser J Buchanan; John F Orr; David C Barton; Ruth K Wilcox
Journal:  J Biomech       Date:  2012-12-20       Impact factor: 2.712

3.  Traumatic spinal fracture treated by vertebroplasty: a case report.

Authors:  Gabriel Claudiu Tender; Daniel Serban
Journal:  J Med Case Rep       Date:  2012-11-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.